Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Lilly is positioning retatrutide as an option for patients seeking more significant weight loss than what can be achieved with the available GLP-1 therapies
in clinical use, the best-known GIP-related medication is tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for weight management, and it is called a dual GIP/GLP-1 receptor agonist because it acts on both pathways
They have a dietary framework, fat-adapted metabolism, and reduced dependence on carbohydrate-driven hunger cycles
Intervention: Treatment with any GLP-1RA (e.g., Semaglutide, liraglutide, dulaglutide)
US$ 24.90
US$ 27.06
US$ 27.73
US$ 29.75
US$ 19.99
US$ 22.78
US$ 24.43
